Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Vulvar Neoplasms × atezolizumab × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 27 Triple Negative Breast Neoplasms 13 Carcinoma, Transitional Cell 12 Breast Neoplasms 12 Urinary Bladder Neoplasms 11 Small Cell Lung Carcinoma 10 Neoplasms 8 Melanoma 8 Carcinoma, Hepatocellular 6 Neoplasm Metastasis 5 Lung Neoplasms 5 Uterine Cervical Neoplasms 4 Ovarian Neoplasms 4 Lymphoma 4 Colorectal Neoplasms 4 Carcinoma, Renal Cell 4 Recurrence 3 Lymphoma, Follicular 3 Leukemia, Myeloid, Acute 3 Brain Neoplasms 3 Solid Tumors 2 Prostatic Neoplasms 2 Lymphoma, Large B-Cell, Diffuse 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Carcinoma 2 Biliary Tract Neoplasms 2 Uterine Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1

Interventions

Platinum 2 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2 Cisplatin 2 Biopsy 2 1,2-diaminocyclohexaneplatinum II citrate 2 fludarabine phosphate 1 fludarabine 1 alovudine 1 aldesleukin 1 Vaccines, Synthetic 1 Sonazoid 1 Respiratory Function Tests 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiosurgery 1 Prochlorperazine 1 Positron-Emission Tomography 1 Ondansetron 1 O(6)-codeine methyl ether 1 Meperidine 1 Magnetic Resonance Imaging 1 Loperamide 1 Interleukin-2 1 Innovar 1 Indomethacin 1 Imiquimod 1 Hydroxyzine 1 Granisetron 1 Gemcitabine 1 Fondaparinux 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡